Simplex Trading’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $179K | Buy |
+58,608
| New | +$233K | ﹤0.01% | 4852 |
|
|
2026
Q1 | – | Sell |
-30,522
| Closed | -$122K | – | 9681 |
|
|
2025
Q4 | $116K | Sell |
30,522
-184,940
| -86% | -$719K | ﹤0.01% | 4844 |
|
|
2025
Q3 | $695K | Buy |
215,462
+75,038
| +53% | +$281K | ﹤0.01% | 3436 |
|
|
2025
Q2 | $405K | Buy |
140,424
+140,160
| +53,091% | +$324K | ﹤0.01% | 3736 |
|
|
2025
Q1 | $0 | Buy |
+264
| New | +$834 | ﹤0.01% | 9155 |
|
|
2024
Q4 | – | Sell |
-26,262
| Closed | -$173K | – | 9149 |
|
|
2024
Q3 | $172K | Buy |
26,262
+1,708
| +7% | +$13.7K | ﹤0.01% | 4671 |
|
|
2024
Q2 | $178K | Sell |
24,554
-36,346
| -60% | -$278K | ﹤0.01% | 4767 |
|
|
2024
Q1 | $462K | Buy |
+60,900
| New | +$475K | ﹤0.01% | 3934 |
|
|
2023
Q2 | – | Sell |
-161
| Closed | -$657 | – | 9522 |
|
|
2023
Q1 | $0 | Buy |
161
+58
| +56% | +$303 | ﹤0.01% | 9662 |
|
|
2022
Q4 | $0 | Sell |
103
-203
| -66% | -$693 | ﹤0.01% | 9876 |
|
|
2022
Q3 | $0 | Buy |
+306
| New | +$767 | ﹤0.01% | 10473 |
|
|
2022
Q2 | – | Sell |
-46
| Closed | -$136 | – | 10592 |
|
|
2022
Q1 | $0 | Sell |
46
-836
| -95% | -$5.47K | ﹤0.01% | 10978 |
|
|
2021
Q4 | $9K | Buy |
882
+725
| +462% | +$8.06K | ﹤0.01% | 9121 |
|
|
2021
Q3 | $1K | Hold |
157
| – | – | ﹤0.01% | 9652 |
|
|
2021
Q2 | $1K | Buy |
+157
| New | +$1.77K | ﹤0.01% | 9831 |
|
|
2019
Q3 | – | Sell |
-516
| Closed | -$7K | – | 7601 |
|
|
2019
Q2 | $7K | Buy |
516
+197
| +62% | +$5.25K | ﹤0.01% | 6298 |
|
|
2019
Q1 | $10K | Sell |
319
-15
| -4% | -$769 | ﹤0.01% | 6156 |
|
|
2018
Q4 | $19K | Buy |
334
+325
| +3,611% | +$32.1K | ﹤0.01% | 5372 |
|
|
2018
Q3 | $1K | Sell |
9
-21
| -70% | -$2.55K | ﹤0.01% | 7202 |
|
|
2018
Q2 | $3K | Sell |
30
-23
| -43% | -$1.95K | ﹤0.01% | 6928 |
|
|
2018
Q1 | $4K | Buy |
+53
| New | +$4.49K | ﹤0.01% | 4803 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6359 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6289 |
|
|
2017
Q2 | – | Sell |
-67
| Closed | -$3.43K | – | 6483 |
|
|
2017
Q1 | $3K | Buy |
+67
| New | +$3.33K | ﹤0.01% | 5018 |
|
|
2016
Q4 | – | Sell |
-610
| Closed | -$24.7K | – | 6228 |
|
|
2016
Q3 | $24K | Buy |
610
+507
| +492% | +$23K | ﹤0.01% | 2794 |
|
|
2016
Q2 | $7K | Sell |
103
-63
| -38% | -$4.98K | ﹤0.01% | 3938 |
|
|
2016
Q1 | $13K | Buy |
166
+74
| +80% | +$5.84K | ﹤0.01% | 3217 |
|
|
2015
Q4 | $6K | Sell |
92
-821
| -90% | -$132K | ﹤0.01% | 3744 |
|
|
2015
Q3 | $350K | Buy |
913
+504
| +123% | +$227K | 0.03% | 588 |
|
|
2015
Q2 | $170K | Buy |
+409
| New | +$171K | 0.01% | 886 |
|
Other funds holding LRMR
DM
BOCH
DCM
DCM
RI
DCM
Simplex Trading's LRMR Position: Q2 2026 in Review
Simplex Trading opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 58,608 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #4852 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LRMR as recently as Q4 2025.
Simplex Trading first reported a position in LRMR in Q2 2015 and has held it in 28 quarters since. The position peaked at $695K in Q3 2025. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.
- Simplex Trading held 58,608 shares of Larimar Therapeutics worth $179K as of Q2 2026.
- Larimar Therapeutics was a new Simplex Trading position in Q2 2026.
- Larimar Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4852 holding.
- Simplex Trading first reported a position in Larimar Therapeutics in Q2 2015 and has held it in 28 quarters since.
- Simplex Trading's Larimar Therapeutics position peaked at $695K in Q3 2025.
- 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.